Australian idiopathic pulmonary fibrosis registry: Vital lessons from a national prospective collaborative project

Respirology

Volumn 19, Issue 7, 2014, Pages 1088-1091

  Moodley, Yuben ^a   Goh, Nicole ^b   Glaspole, Ian ^b   Macansh, Sacha ^c   Walters, E Haydn ^d   Chapman, Sally ^e   Hopkins, Peter ^f   Reynolds, Paul N ^e   Zappala, Christopher ^g   Cooper, Wendy ^h,i,j   Mahar, Annabelle ^h,i   Ellis, Samantha ^b   McCormack, Samuel ^h   Darbishire, William ^c   Wood Baker, Richard ^d   Corte, Tamera J ^h,i   Fuller, Joanne ^a   McAlister, Mary ^a   Stevens, Emily ^a   Symons, Karen ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c Lung Foundation Australia   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

^e ROYAL ADELAIDE HOSPITAL   (Australia)

^f THE PRINCE CHARLES HOSPITAL   (Australia)

^g ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^h ROYAL PRINCE ALFRED HOSPITAL   (Australia)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j UNIVERSITY OF WESTERN SYDNEY   (Australia)

more..

Author keywords

Australia; Epidemiology; Idiopathic pulmonary fibrosis; Natural history; Registry

Indexed keywords

ARTICLE; AUSTRALIA; AUSTRALIAN; FIBROSING ALVEOLITIS; HUMAN; INCIDENCE; PERSONAL EXPERIENCE; PROSPECTIVE STUDY; REGISTER; IDIOPATHIC PULMONARY FIBROSIS;

AUSTRALIA; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; REGISTRIES;

EID: 84908612445     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12358     Document Type: Article

References (8)

1. King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am. J. Respir. Crit. Care Med. 2001;164:1171-81.
2. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med. 2002;165:277-304.
3. Wells AU, Hirani N. Interstitial lung disease guidelines: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008;63:S1-58.
4. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2006;174:810-16.
5. Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson CG, Brown KK. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am. J. Respir. Crit. Care Med. 2007;176:277-84.
6. Olson AL, Swigris JJ. Idiopathic pulmonary fibrosis: diagnosis and epidemiology. Clin. Chest Med. 2012;33:41-50.
7. Wilson JW, du Bois RM, King TE Jr. Challenges in pulmonary fibrosis: 8-the need for an international registry for idiopathic pulmonary fibrosis. Thorax 2008;63:285-7.
8. Spagnolo P, du Bois RM, Cottin V. Rare lung disease and orphan drug development. Lancet Resp Med 2013;1:479-87.